Article

Mmarketwatch.com on 2020-06-15 13:44

Progenity to offer 6.7 million shares in planned IPO priced at $14 to $16 each

Biotech Progenity Inc. undefined set terms for its planned initial public offering on Monday, with plans to offer 6.7 million shares priced at $14 to ...

Related news

MTrevi Therapeutics to offer 6.7 million shares in planned IPO priced at $14 to $16 each marketwatch.com
Needham
MBiotech Oncorus to offer 5.8 million shares in planned IPO, priced at $14 to $16 each marketwatch.com
MAssetMark Financial to offer 12.5 million shares in planned IPO, priced at $19 to $21 each marketwatch.com
MHarmony Biosciences to offer 4.65 million shares in planned IPO, priced at $20 to $23 each marketwatch.com
MBiotech Nurix Therapeutics to offer 11 million shares in planned IPO, priced at $17 to $18 each marketwatch.com
Needham
MAxonics to offer 6.7 million shares in IPO, priced at $14 to $16 each marketwatch.com
MBiotech Arvinas to offer 6.7 million shares in IPO priced at $14 to $16 each marketwatch.com
MBiotech Cibus to offer 6.7 million shares in IPO, priced at $14 to $16 each marketwatch.com
MHookipa Pharma to offer 6.7 million shares in IPO, priced at $14 to $16 each marketwatch.com
MDyne Therapeutics to offer 10.3 million shares in IPO priced at $16 to $18 each marketwatch.com
MOrigin Bancorp to offer 3.6 million shares in IPO, priced at $33 to $35 each marketwatch.com
Ruston
MMirum Pharmaceuticals to offer 5 million shares in IPO, priced at $14 to $16 each marketwatch.com
MCentogene to offer 4 million shares in planned IPO priced at $14 to $16 each marketwatch.com
MLyra Therapeutics to offer 3.5 million shares in planned IPO, priced at $14 to $16 each marketwatch.com
MSurveyMonkey to offer 13.5 million shares in planned IPO, priced at $9 to $11 each marketwatch.com
MGreenwich LifeSciences to offer 1 mln shares in planned IPO, priced at $7.50 to $8.50 each marketwatch.com
MBiotech Inhibrx to offer 6 million shares in planned IPO, priced at $16 to $18 each marketwatch.com
MRapt Therapeutics to offer 3 million shares in planned IPO priced at $12 to $14 each marketwatch.com
MBiotech Alzheon to offer 6 million shares in planned IPO priced at $4 to $6 each marketwatch.com
M10x Genomics to offer 9 million shares in planned IPO, priced at $31 to $35 each marketwatch.com